Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

28.67 +1.16 (+4.22%)
Streaming Delayed Price Updated: 11:04 AM EDT, Sep 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
59 60 Next >
News headline image
HIMS Stock Jumps 14% – Barclays Says Market Is Underestimating Opportunity From New Products ↗
Brokerages have turned bullish on HIMS since its deal with Novo Nordisk earlier this week, with Barclays raising the stock’s price target to $29. 
Via Stocktwits
Topics Intellectual Property Lawsuit
News headline image
Short Seller Who Bet Against Hims & Hers Now Says Its CEO 'Wiped The Floor' With Novo Nordisk ↗
Hunterbrook had shorted Hims in 2024, warning its GLP-1 strategy relied on a regulatory loophole during drug shortages and could face legal risks tied to patents. 
Via Stocktwits
Topics Bankruptcy Fraud Intellectual Property
News headline image
3 Big Reasons to Love Hims & Hers Health (HIMS)
Hims & Hers Health has gotten torched over the last six months - since September 2025, its stock price has dropped 55.2% to $23.21 per share. This may have i... 
Via StockStory
News headline image
Hims & Hers Names Kathryn Beiser as Chief Communications Officer
From Hims & Hers
Via Business Wire
News headline image
Asset Manager Exits Shares of Hims & Hers Health ↗
Hims & Hers Health has struggled, but it just inked a new partnership with Novo Nordisk. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Patience Pays: Hims & Hers Surges on News of Novo Nordisk Deal ↗
Via MarketBeat
News headline image
Disrupting the Pharmacy: A Deep-Dive into Hims & Hers Health (HIMS) in 2026
As of March 10, 2026, the telehealth landscape has undergone a radical transformation, and few companies embody this shift more than Hims & Hers Health, Inc. (NYSE: HIMS). Once dismissed as a... 
Via Finterra
Topics Artificial Intelligence Economy
News headline image
Novo Nordisk-Hims Deal Turns Wall Street Bullish — BMO Sees Relief From Commercial Headwinds, BofA Upgrades HIMS Stock ↗
BMO Capital maintained its ‘Market Perform’ rating for Novo Nordisk, with a price target of $45, implying an upside of more than 13% from NVO stock’s closing price on Monday. 
Via Stocktwits
Topics Intellectual Property Lawsuit
News headline image
Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers
From Hims & Hers
Via Business Wire
From Red to Green: How Trump's Iran Endgame Sparked a Wall Street Comeback ↗
Via Chartmill
Topics Government
News headline image
HIMS Stock Rockets To Best Day Ever After Novo Nordisk Pact — Wall Street Upgrades Roll In As Shorts Lose $546M In One Day ↗
Short interest totalled about $1.39 billion, or roughly 42.83% of the float, according to S3 Partners. 
Via Stocktwits
Topics Intellectual Property Lawsuit
News headline image
Stock Market Today, March 9: Hims & Hers Health Soars on Novo Nordisk Weight-Loss Drug Deal ↗
On March 9, 2026, a new Novo Nordisk pact reshaped this telehealth player’s GLP-1 strategy, margins, and legal risk profile. 
Via The Motley Fool
Topics Intellectual Property Lawsuit Stocks
Top stock movements in today's session. ↗
Via Chartmill
These stocks are making the most noise in today's session. ↗
Via Chartmill
News headline image
The Great 2026 Pivot: Tangible Assets Surge as Tech Giants Falter in Massive Sector Rotation
The financial landscape on March 9, 2026, has reached a critical tipping point, marking one of the most aggressive sector rotations in modern market history. As technology-heavy indices struggle to... 
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
News headline image
ENDRA Life Sciences (NASDAQ: NDRA): The GLP-1 Healthcare Boom Offering Tremendous Opportunity Watch HIMS, ANTX, ATAI, PURR Now!
Via AB Newswire
Monday's session: top gainers and losers ↗
Via Chartmill
News headline image
Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Hims & Hers Health Shares Skyrocket on Novo Nordisk Deal, but Is the Stock Still a Buy? ↗
Hims & Hers stock traded more than 40% higher after the deal was announced. 
Via The Motley Fool
Topics Lawsuit
News headline image
Hims & Hers Stock Pops 40%: Everything You Need to Know ↗
Hims & Hers shares are up over 40% on Monday after announcing a deal with Novo Nordisk. 
Via The Motley Fool
Topics Lawsuit
News headline image
Why Hims & Hers Health (HIMS) Stock Is Up Today
What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 41.7% in the morning session after the company announced a collaboration wi... 
Via StockStory
Topics Economy Lawsuit Stocks
Gapping stocks in Monday's session ↗
Via Chartmill
News headline image
The Pivot to Legitimacy: Hims & Hers Health (HIMS) Faces a New Era of Personalized Medicine
Date: March 9, 2026Sector: Healthcare TechnologyCompany: Hims & Hers Health, Inc. (NYSE: HIMS) Introduction As of March 9, 2026, Hims & Hers Health, Inc. (NYSE: HIMS) finds itself at perhaps the most... 
Via Finterra
Topics Artificial Intelligence Economy
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
HIMS Stock Soars After Novo Nordisk Drops Patent Infringement Lawsuit, Opens Access To Ozempic, Wegovy ↗
Hims & Hers also stated that it will no longer advertise compounded GLP-1 offerings on its platform or in its marketing. 
Via Stocktwits
Topics Intellectual Property Lawsuit
News headline image
Hims & Hers Announces Strategic Shift for US Weight Loss Business
From Hims & Hers
Via Business Wire
News headline image
Oil Shock Sends Nasdaq, S&P 500 Futures Lower: Why USO, INDO, HIMS, NVDA Are On Traders' Radar Today ↗
Data from Stocktwits showed that retail sentiment on SPY and QQQ remains ‘bearish.’ 
Via Stocktwits
Topics ETFs Economy Government
News headline image
HIMS Stock Could Rally Up To 60% This Week? Fund Manager Says He Wouldn’t Be ‘Surprised’ As Novo Nordisk Patch-Up Buzz Grows ↗
Lupton Capital CEO Jonah Lupton said the potential agreement could include both injectable and oral GLP-1 drugs. 
Via Stocktwits
Topics Intellectual Property Lawsuit
News headline image
Novo Nordisk To Partner With Hims & Hers To Sell Weight-Loss Drugs: Report ↗
According to J.P. Morgan, the market for weight-loss drugs will become one of the biggest and fastest-growing in healthcare. 
Via Stocktwits
Topics Initial Public Offering Intellectual Property Lawsuit
News headline image
Tariffs News & Market Chaos ↗
President Trump's tariffs have been overturned, throwing the market into even more chaos in 2026. 
Via The Motley Fool
Topics Economy Government World Trade
< Previous 1 2 3 4 5 6 7 8 9
...
59 60 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.